Avraham Neta
Research Subjects
Avraham Neta has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Eyal Kaufman
Javelin Medical Ltd. Yokne'am, Israel
1 shared publicationGuy Shinar
Javelin Medical Ltd. Yokne'am, Israel
1 shared publication- Guy Shinar
Javelin Medical Ltd., Yokne’am, Israel
1 shared publication Ofer Yodfat
Javelin Medical Ltd. Yokne'am, Israel
1 shared publication- Ofer Yodfat
Javelin Medical Ltd., Yokne’am, Israel
1 shared publication - Petr Neuzil
Na Homolce Hospital , Prague, Czechia
1 shared publication
Latest Publications
- Open Access
- 1 December 2020
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 21 (12) , 1587-1593
A Permanent Common Carotid Filter for Stroke Prevention in Atrial Fibrillation: Ex Vivo and In Vivo Pre-Clinical Testing
- 1 December 2020
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 21 (12) , 1587-1593
Open AccessA Permanent Common Carotid Filter for Stroke Prevention in Atrial Fibrillation: Ex Vivo and In Vivo Pre-Clinical Testing
- Open Access
- 10 September 2020
- Published by Springer Nature in Current Cardiology Reports
- Vol. 22 (11) , 1-10
Permanent Bilateral Carotid Filters for Stroke Prevention in Atrial Fibrillation
Purpose of Review: A novel permanent carotid filter device for percutaneous implantation was developed for the purpose of stroke prevention. In this review, we cover rationale, existing preclinical and clinical data, and potential future directions for research using such a device. Recent Findings: The Vine™ filter was assessed for safety in sheep and in 2 observational human studies, the completed CAPTURE 1 (n = 25) and the ongoing CAPTURE 2 (planned n = 100). CAPTURE 1 has shown high procedural and long-term implant safety. A control group was not available for comparison. Summary: A mechanical filter for permanent stroke prevention can be implanted bilaterally in the common carotid artery safely and efficiently. A randomized trial is planned for 2021 (n = 3500, INTERCEPT) to demonstrate superiority of a filter + anticoagulation strategy over anticoagulation alone in patients at high risk for ischemic stroke.
- 10 September 2020
- Published by Springer Nature in Current Cardiology Reports
- Vol. 22 (11) , 1-10
Open AccessPermanent Bilateral Carotid Filters for Stroke Prevention in Atrial Fibrillation
Purpose of Review: A novel permanent carotid filter device for percutaneous implantation was developed for the purpose of stroke prevention. In this review, we cover rationale, existing preclinical and clinical data, and potential future directions for research using such a device. Recent Findings: The Vine™ filter was assessed for safety in sheep and in 2 observational human studies, the completed CAPTURE 1 (n = 25) and the ongoing CAPTURE 2 (planned n = 100). CAPTURE 1 has shown high procedural and long-term implant safety. A control group was not available for comparison. Summary: A mechanical filter for permanent stroke prevention can be implanted bilaterally in the common carotid artery safely and efficiently. A randomized trial is planned for 2021 (n = 3500, INTERCEPT) to demonstrate superiority of a filter + anticoagulation strategy over anticoagulation alone in patients at high risk for ischemic stroke.